• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

NAKAYAMA TAKAYUKI  中山 貴之

ORCIDConnect your ORCID iD *help
… Alternative Names

中山 貴之  ナカヤマ タカユキ

Nakayama Takayuki  中山 貴之

Less
Researcher Number 10727225
Other IDs
Affiliation (Current) 2022: 埼玉医科大学, 医学部, 助教
2022: 東京医科歯科大学, 医学部附属病院, 非常勤講師
Affiliation (based on the past Project Information) *help 2020: 埼玉医科大学, 医学部, 助教
2019: 国立研究開発法人国立がん研究センター, 先端医療開発センター, 研究員
2015 – 2016: 東京医科歯科大学, 医学部附属病院, 医員
Review Section/Research Field
Principal Investigator
Urology / Basic Section 56030:Urology-related
Except Principal Investigator
Basic Section 56030:Urology-related
Keywords
Principal Investigator
前立腺癌 / 放射線治療 / 化学療法 / 放射線療法 / 放射線 / 抗癌剤 / 治療耐性因子 / 腎細胞癌 / 腫瘍免疫 / 免疫チェックポイント阻害薬 / 腎細胞がん … More
Except Principal Investigator
… More 腎細胞がん / 炎症 / 免疫 / C反応性蛋白 / 免疫チェックポイント阻害剤 / 免疫療法 / 腎細胞癌 / 抗腫瘍免疫 Less
  • Research Projects

    (3 results)
  • Research Products

    (1 results)
  • Co-Researchers

    (2 People)
  •  腎細胞がんにおける炎症と免疫の関連メカニズムの解明とその新規免疫療法への応用

    • Principal Investigator
      齋藤 一隆
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Dokkyo Medical University
      Tokyo Medical and Dental University
  •  多重免疫染色解析システムを用いたがん免疫療法の治療効果予測モデル構築Principal Investigator

    • Principal Investigator
      中山 貴之
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Saitama Medical University
      National Cancer Center Japan
  •  Zoledronic acid sensitizes castration resistant prostate cancer cells to radiotherapy and chemotherapy by downregulating STAT1Principal Investigator

    • Principal Investigator
      Nakayama Takayuki
    • Project Period (FY)
      2015 – 2016
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Urology
    • Research Institution
      Tokyo Medical and Dental University

All 2017

All Presentation

  • [Presentation] Zoledronic acid sensitizes castration-resistant prostate cancer cells to radiotherapy and chemotherapy by downregulating STAT12017

    • Author(s)
      Takayuki Nakayama
    • Organizer
      The 112th annual meeting of the American Urological Association
    • Place of Presentation
      Boston, USA
    • Year and Date
      2017-05-13
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K20072
  • 1.  齋藤 一隆 (10422495)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 2.  北野 滋久 (60402682)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to connect your ORCID iD to this researcher?
* This action can be performed only by the researcher themselves.

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi